Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacological Ascorbate Combined With Radiation and Temozolomide in Glioblastoma Multiforme
NCT02344355Phase 2Active, not recruiting
- Start
- Mar 2017
- Primary completion
- Dec 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ascorbic acid in glioblastoma multiforme (GBM). Started Mar 2017; status: active, not recruiting.
02
Drugs
ascorbic acid
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT02344355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02344355.